Tag: DCGI
Drugs regulator suspends nod to PresVu eye drop
The Drugs Controller General of India (DCGI) has suspended the approval granted to Entod Pharmaceuticals' PresVu (Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25% w/v) eye...
Glenmark launches biosimilar of anti-diabetic drug Liraglutide
Glenmark Pharmaceuticals, a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic drug, Liraglutide, for the first time in India. The...
Nod for Bharat Biotech’s intranasal ‘five arms’ Covid-19 booster
India’s drug controller has approved vaccine manufacturer Bharat Biotech's intranasal 'five arms' Covid-19 booster dose for restricted use, news agency IANS and ANI reported...
Dalmia gets nod from Ministry of Ayush for manufacturing of Astha-15
Dalmia Healthcare will soon be announcing the launch of the polyherbal combination of 15 herbs called Astha-15 for the treatment of Covid-19 and standard...
FDC introduces stronger versions of Favipiravir drugs PiFLU & Favenza
Home-grown pharma major, Delhi-based FDC, announced the launch of new strength variants of its Favipiravir brands– PiFLU and Favenza, used to treat mild to...
Cipla & Stempeutics collaborate for launch of Stempeucel
Cipla announced that its partner Stempeutics Research has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel...
DCGI approves Phase II &III trials of Oxford University vaccine
The Drugs Controller General of India (DCGI) has approved the Serum Institute of India, Pune, to conduct Phase II&III clinical trials of Oxford University-Astra...
Pneumococcal Polysaccharide conjugate vaccine gets DCGI nod
Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide conjugate vaccine. This vaccine has been developed...
DCGI nods for restricted emergency use of Itolizumab for Covid-19 patients
Itolizumab (rDNA origin), a monoclonal antibody that was already approved for severe chronic plaque psoriasis, has now been granted Restricted Emergency Use authorization by...
Bharat Biotech’s COVAXIN gets approval for phase I & II human...
Hyderabad-based Bharat Biotech has successfully developed COVAXIN, India’s 1st vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) -...